Immunosuppressants in Brazil: underlying drivers of spending trends, 2010

Immunosuppressants in Brazil: underlying drivers of spending trends, 2010–2015

Published:2018-06-14 Issue:5 Volume:18 Page:565-572
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Alves Jéssica de Castro¹,Osorio-de-Castro Claudia Garcia Serpa²,Wettermark Bjorn³,Luz Tatiana Chama Borges¹

Affiliation:

1. René Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte, Minas Gerais, Brazil

2. Department of Pharmaceutical Policies and Pharmaceutical Services (NAF), Sergio Arouca National School of Public Health/Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil

3. Department of Medicine, Clinical Epidemiology, Karolinska Institutet, Solna (MedS), K2, Stockholm, Sweden

Funder

Brazilian Research and Development Council

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2018.1485098

Reference29 articles.

1. Trends in medicines procurement by the Brazilian federal government from 2006 to 2013

2. Key Components of Increased Drug Expenditure in South Korea: Implications for the Future

3. The Effect of Changes in Treatment Patterns on Drug Expenditure

4. New approaches to analysing prescription data and to transfer pharmacoepidemiological and evidence-based reports to prescribers

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries;BioDrugs;2023-12-08

2. Performance of a pharmaceutical services regionalization strategy policy in Minas Gerais, Brazil: Pre-post analysis from ERAF project;Frontiers in Pharmacology;2022-09-02

3. What is the major driver of China’s hospital medical expenditure growth? A decomposing analysis;BMJ Open;2022-02

4. Data Sources for Drug Utilization Research in Brazil—DUR-BRA Study;Frontiers in Pharmacology;2022-01-14

5. Indutores do gasto federal em medicamentos do componente especializado: medição e análise;Revista de Saúde Pública;2021-12-08